A herpesvirus vector can transduce axotomized brain neurons

Experimental Neurology

Volumn 183, Issue 2, 2003, Pages 548-558

  Rogers, John H ^a   Rhodes, Kate ^a,b   Roberts, Suzanne ^a   Raza, Mansoor ^a   Muir, Elizabeth M ^a   Fawcett, James W ^a,b   Scarpini, Cinzia G ^a   Efstathiou, Stacey ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain injury; Gene therapy; Herpes simplex; Neural regeneration; Nigrostriatal tract; Parabrachial nuclei; Substantia nigra

Indexed keywords

BETA GALACTOSIDASE; HERPESVIRUS VECTOR; PROTEIN C JUN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOMEGALOVIRUS VECTOR; FEMALE; GENE EXPRESSION; IMMUNOFLUORESCENCE; MEDIAL FOREBRAIN BUNDLE; NERVE FIBER TRANSECTION; NONHUMAN; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TRANSGENE;

EID: 0141671986     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00187-0     Document Type: Article

References (41)

1. Airaksinen M.S., Saarma M. The GDNF family signalling, biological functions and therapeutic value . Nature Rev. Neurosci. 3:2002;383-394.
2. Bahr B.A., Neve R.L., Sharp J., Geller A.I., Lynch G. Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector. Mol. Brain Res. 26:1994;277-285.
3. Beck K.D., Valverde J., Alexi T., Poulson K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
4. Bradbury E.J., Moon L.D.F., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.F., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
5. Brecknell J.E., Dunnett S.B., Fawcett J.W. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience. 64:1995;219-227.
6. Brecknell J.E., Haque N.S.K., Du J.S., Muir E., Fidler P.S., Hlavin M.-L., Fawcett J.W., Dunnett S.B. Functional and anatomical reconstruction of the 6-OHDA-lesioned nigrostriatal system of the adult rat. Neuroscience. 71:1996;913-915.
7. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses a case for more uniform standards of review . J. Comp. Neurol. 364:1996;6-15.
8. DeGiorgio L.A., Shimizu Y., Chun H.S., Cho B.-P., Sugama S., Joh T.H., Volpe B.T. APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomy. Glia. 38:2002;174-178.
9. Fawcett J.W., Asher R.A. Review the glial scar and CNS repair . Brain Res. Bull. 49:(6):1999;377-391.
10. Fink D.J., DeLuca N.A., Goins W.F., Glorioso J.C. Review gene transfer to neurons using HSV-based vectors . Annu. Rev. Neurosci. 19:1996;265-287.
11. Hagg T., Varon S. CNTF prevents degeneration of adult rat SN dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA. 90:1993;6315-6319.
12. Horner P.J., Gage F.H. Review regenerating the damaged CNS . Nature. 407:2000;963-970.
13. Howard M.K., Kershaw T., Gibb B., Storey N., MacLean A.R., Zeng B.Y., Tel B.C., Jenner P., Brown S.M., Woolf C.I., Anderson P.N., Coffin R.S., Latchman D.S. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther. 5:1998;1137-1147.
14. Hughes P.E., Alexi T., Walton M., Williams C.E., Dragunow M., Clark R.G., Gluckman P.D. Activity- and injury-dependent expression of inducible transcription factor, growth factors, and apoptosis-related genes within the CNS. Prog. Neurobiol. 57:1999;421-450.
15. Hunt S.P., Mantyh P.W. The molecular dynamics of pain control. Nature Rev. Neurosci. 2:2001;83-91.
16. Jacobs A., Breakefield X.O., Fraefel C. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors II. Vector systems and applications . Neoplasia. 1:1999;402-416.
17. Kaplitt M.G., Pfaus J.G., Kleopoulos S.P., Hanlon B.A., Rabkin S.D., Pfaff D.W. Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a HSV-1 defective viral vector. Mol. Cell. Neurosci. 2:1991;320-330.
18. Knüsel B., Beck K.D., Winslow J.W., Rosenthal A., Burton L.E., Widmer H.R., Nikolics K., Hefti F. BDNF administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12:1992;4391-4402.
19. Krisky D.M., Wolfe D., Goins W.F., Marconi P.C., Ramakrishnan R., Mata M., Rouse R.J.D., Fink D.J., Glorioso J.C. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5:1998;1593-1603.
20. Lachmann R.H., Efstathiou S. Utilization of the HSV-1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J. Virol. 71:1997;3197-3207.
21. Lachmann, R.H., Efstathiou, S., 1997b. Review: the use of herpes simplex virus-based vectors for gene delivery to the nervous system. Mol. Med. Today 404-411.
22. Latchman D.S., Coffin R.S. Viral vectors for gene therapy in Parkinson's disease. Rev. Neurosci. 12:2001;69-78.
23. Leah J.D., Herdegen T., Murashow A., Dragunow M., Bravo R. Expression of immediate early gene proteins following axotomy and inhibition of axonal transport in the rat CNS. Neuroscience. 57:1993;53-66.
24. Lilley C.E., Groutsi F., Han Z.Q., Palmer J.A., Anderson P.N., Latchman D.S., Coffin R.S. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 75:2001;4343-4356.
25. Natsume A., Mata M., Wolfe D., Oligino T., Goss J., Huang S.H., Glorioso J., Fink D.J. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J. Neurotrauma. 19:2002;61-68.
26. Nieuwenhuys R., Geeraedts L.M.G., Veening J.G. The medial forebrain bundle of the rat I. General introduction . J. Comp. Neurol. 206:1982;49-81.
27. Palella T.D., Hidaka Y., Silverman L.J., Levine M., Glorioso J., Kelley W.N. Expression of human HPRT mRNA in brains of mice infected with a recombinant HSV-1 vector. Gene. 80:1989;137-144.
28. Paxinos, G. (Ed.), 1985. The Rat Nervous System, Academic Press, Sydney.
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sydney.
30. Ramer M.S., Harper G.P., Bradbury E.J. Progress in spinal cord research a refined strategy for the International Spinal Research Trust . Spinal Cord. 38:2000;449-472.
31. Sandler V.M., Wang S., Angelo C., Lo H.G., Breakefield X.O., Clapham D.E. Modified HSV delivery of enhanced GFP into the CNS. J. Neurosci. Methods. 121:2002;211-219.
32. Scarpini C.G., Arthur J., Efstathiou S., McGrath Y., Wilkinson G. Herpes simplex virus and adenovirus vectors. Cann A.J. DNA Viruses A Practical Approach . 1999;267-300 Oxford Univ. Press, Oxford.
33. Scarpini C.G., May J., Lachman R.H., Preston C.M., Dunnett S.B., Torres E.M., Efstathiou S. Latency-associated promoter transgene expression in the CNS after stereotaxic delivery of replication-defective HSV-1-based vectors. Gene Ther. 8:2001;1057-1071.
34. Simonato M., Manservigi R., Marconi P., Glorioso J. Review gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors . Trends Neurosci. 23:2000;183-190.
35. Starr P.A., Lim F., Grant F.D., Trask L., Lang P., Yu L., Geller A.I. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther. 3:1996;615-623.
36. Song S., Wang Y.M., Bak S.Y., Lang P., Ullrey D., Neve R.L., OMalley K.L., Geller A.I. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J. Neurochem. 68:1997;1792-1803.
37. Von Bartheld C.S. Comparison of 2-D and 3-D counting the need for calibration and common sense . Trends Neurosci. 24:2001;504-506.
38. Wilby M.J., Sinclair S.R., Muir E.M., Zietlow R., Adcock K.H., Horellou P., Rogers J.H., Dunnett S.B., Fawcett J.W. A GDNF-secreting clone of the Schwann cell line SCTM41 enhances survival and fibre outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J. Neurosci. 19:1999;2301-2312.
39. Wolfe D., Goins W.E., Yamada M., Moriuchi S., Krisky D.M., Oligino T.J., Marconi P.C., Fink D.J., Glorioso J.C. Engineering herpes simplex virus vectors for CNS applications. Exp. Neurol. 159:1999;34-46.
40. Yamada M., Oligino T., Mata M., Goss J.R., Glorioso J.C., Fink D.J. HSV-mediated expression of Bcl-2 prevents 6-OHDA-induced degeneration of neurons in the substantia nigra in vivo. Proc. Nat. Acad. Sci. USA. 96:1999;4078-4083.
41. Zhou F.C., Chiang Y.H., Wang Y. Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra. J. Neurosci. 16:1996;6965-6974.